Joincare discloses guarantee balance of 2.069 billion yuan as annual and quarterly reports show declines in both revenue and net profit

Corporate Action
โดย 读创财经·CN·Read original
Summary · why it matters

Joincare disclosed that as of July 31, 2026, its total guarantee balance stood at 2.069 billion yuan, accounting for 13.63% of its latest audited net assets. This includes 1.842 billion yuan in guarantees for wholly owned and controlled subsidiaries, and 227 million yuan in guarantees for its joint venture Jinguan Electric Power, with no overdue external guarantees. In July 2026, the company and its controlled subsidiary Livzon Pharmaceutical Group signed multiple guarantee contracts with China Merchants Bank, ICBC, and Bank of Communications, involving entities such as Joincare Haibin Pharmaceutical, Jiaozuo Joincare Biological Products, Shenzhen Taitai Pharmaceutical, Xinxiang Haibin Pharmaceutical, Livzon Group Livzon Pharmaceutical Factory, Sichuan Guangda Pharmaceutical, Zhuhai Livzon Pharmaceutical Trading, Livzon Group Ningxia Pharmaceutical, Livzon Group New Beijiang Pharmaceutical, and Jiaozuo Livzon Synthetic Pharmaceutical. Individual guarantee amounts ranged from 30 million yuan to 302 million yuan. The company's 2025 revenue was 15.216 billion yuan, down 2.58% year-on-year, with net profit attributable to shareholders of 1.336 billion yuan, down 3.68% year-on-year, marking the third time in recent years that both revenue and net profit declined. In the first quarter of 2026, revenue was 3.721 billion yuan, down 8.99% year-on-year, and net profit attributable to shareholders was 415 million yuan, down 4.78% year-on-year. As of the close on August 4, the company's stock had fallen nearly 12% for the year.

Impact on stocks 2

Others▼ · 2 stocks
Livzon Pharmaceutical Group Inc
000513
▼ NegativeCapitalrelevance

As a controlled subsidiary, its parent's financial declines and guarantee disclosures reflect negatively on its performance.

Off-coverage companies 1

四川光大制药有限公司Private± Mixed
relevance

© 2026 MarketDXNews